A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay.
Inexpensive, simple, rapid diagnostics are necessary for efficient detection, treatment, and mitigation of COVID-19. Assays for SARS-CoV2 using reverse transcription polymerase chain reaction (RT-PCR) offer good sensitivity and excellent specificity, but are expensive, slowed by transport to central...
Guardado en:
Autores principales: | Benjamin D Grant, Caitlin E Anderson, Luis F Alonzo, Spencer H Garing, John R Williford, Ted A Baughman, Rafael Rivera, Veronika A Glukhova, David S Boyle, Puneet K Dewan, Bernhard H Weigl, Kevin P Nichols |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad82acb0f6cd47f087c370ee780bc055 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay
por: Benjamin D. Grant, et al.
Publicado: (2021) -
Coronavirus nucleocapsid proteins assemble constitutively in high molecular oligomers
por: Yingying Cong, et al.
Publicado: (2017) -
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays.
por: Zahra Rikhtegaran Tehrani, et al.
Publicado: (2020) -
MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity
por: Li Wang, et al.
Publicado: (2021) -
Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients.
por: John T Connelly, et al.
Publicado: (2021)